News

Medscape1d
Treatment of Hypertension in Diabetes
Thiazide diuretics reduce BP at least in part by reversing the underlying tendency to volume expansion in hypertensive diabetic patients. A combination of thiazide and a RAS blocker is ...
US FDA approves an updated label for TRYVIO (aprocitentan) removing the REMS requirement
Michael Moye, President and General Manager of Idorsia US, commented: “The fact that the FDA has expedited the approval of the updated TRYVIO label to remove the REMS requirements is, I believe, a ...
The effect of aprocitentan for reducing blood pressure and proteinuria in Black patients with resistant hypertension published in Hypertension
Aprocitentan, on top of background therapy, showed clinically meaningful and durable blood pressure (BP) reduction and a decrease in proteinuria ...
Nature11mon
Combination therapy for hypertension
Almost all trials of antihypertensive drugs over the past 5 years have involved a comparison of one or two drugs against a different single or combination therapy. The Hypertension in the Very ...
Taiwan News28d
US FDA removes REMS requirement for TRYVIO (aprocitentan) – minimizing the burden on the healthcare delivery systems and patients
TRYVIO is Idorsia’s dual endothelin receptor antagonist (ERA) indicated for the treatment of systemic hypertension in combination with other antihypertensives to lower blood pressure in patients who ...